Brent Furse
Chief Executive Officer at Vero Biotech LLC
Profile
Mr. Brent Furse is a President, Chief Executive Officer & Director at Vero Biotech LLC and a President, Chief Executive Officer & Director at Vero Biotech, Inc. He is on the Board of Directors at Vero Biotech LLC and Vero Biotech, Inc. Mr. Furse was previously employed as an Independent Director by Anthera Pharmaceuticals, Inc., a President & Chief Commercial Officer by Cardiorentis AG, and a Chief Customer Officer & Senior Vice President by The Medicines Co. He received his undergraduate degree from Mercer University, an undergraduate degree from Kennesaw State University and an MBA from Mercer University.
Brent Furse active positions
| Companies | Position | Start |
|---|---|---|
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Chief Executive Officer | 2016-05-31 |
| Vero Biotech, Inc. | Chief Executive Officer | 2016-05-31 |
Former positions of Brent Furse
| Companies | Position | End |
|---|---|---|
| THE MEDICINES COMPANY | Corporate Officer/Principal | 2013-12-31 |
| ANTHERA PHARMACEUTICALS, INC. | Director/Board Member | - |
Cardiorentis AG
 Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | President | - |
Training of Brent Furse
| Mercer University | Masters Business Admin |
| Kennesaw State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Cardiorentis AG
Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Health Technology |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
| Vero Biotech, Inc. |
- Stock Market
- Insiders
- Brent Furse
